increased susceptibility to type IV hypersensitivity reaction_Pla2g2d<tm1.1Mhg>/Pla2g2d<tm1.1Mhg>

http://metadb.riken.jp/0005617B6NCrSlcCgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11Mhg

increased susceptibility to type IV hypersensitivity reaction_Pla2g2d<tm1.1Mhg>/Pla2g2d<tm1.1Mhg>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• phospholipase A2, group IID
  http://metadb.riken.jp/db/mgi_rdf/MGI:1341796

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Pla2g2d<tm1.1Mhg>/Pla2g2d<tm1.1Mhg>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Pla2g2d<tm1.1Mhg>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• B6NCrSlc.Cg-Pla2g2d<tm1.1Mhg>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased susceptibility to type IV hypersensitivity reaction
  http://purl.obolibrary.org/obo/MP_0005617

文献

http://purl.org/net/cito/citesAsAuthority

• Yoshimi. Miki, et.al., Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators., The Journal of experimental medicine, 2013, 210
  http://rdf.ncbi.nlm.nih.gov/pubmed/23690440